Screener
Spyre Therapeutics, Inc. SYRE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.96B.
The source filing: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001636282-26-000050
FAQ
- What is Spyre Therapeutics, Inc.'s market capitalization?
- Spyre Therapeutics, Inc. (SYRE) reported market capitalization of $3.96B in Q1 2026.
- How has Spyre Therapeutics, Inc.'s market capitalization changed year-over-year?
- Spyre Therapeutics, Inc.'s market capitalization increased by 307.5% year-over-year, from $972.25M to $3.96B.
- What is the long-term trend for Spyre Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Spyre Therapeutics, Inc.'s market capitalization has grown at a 43.3% compound annual growth rate (CAGR), from $420.04M to $2.54B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Spyre Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude